EUVIMEDObjevte EUVIMED
Video/Audio

Covalent Fragment Screening Using the Quantitative Irreversible Tethering Assay

Charles P Brown, Alan Armstrong, David J Mann

Journal of Visualized Experiments · 2025

DOI: 10.3791/67178 ↗

At a glance

Video/Audio in Journal of Visualized Experiments, 2025. Written by Charles P Brown and 2 co-authors. Institution: Department of Chemistry, Imperial College London, Molecular Sciences Research Hub; Department of Life Sciences, Imperial College London, South Kensin…. Major MEDLINE topics: Small Molecule Libraries, Drug Discovery. 16 references.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Compounds that form covalent bonds with specific target proteins offer a variety of advantages as chemical probes and therapeutic agents. Most commonly, mildly reactive, electrophilic small molecules are employed to form covalent bonds with select cysteine side chains in specific proteins. Electrophile-first approaches of ligand discovery, whereby a library of electrophilic small molecules are screened against a protein target, have become popular as they avoid the need for time-consuming downstream installation of an electrophilic warhead. Such screening is complicated, however, as electrophilic ligands can exhibit a wide range of different rates of spontaneous reaction with cysteines. Quantitative-irreversible tethering (qIT) offers a fluorescence-based method for hit identification and development that normalizes data for these differences in intrinsic compound reactivity. Rates of reaction of individual compounds with a target protein are determined and compared to compound reactivity with the unstructured tripeptide glutathione (this being a proxy for spontaneous compound reaction), enabling the identification of compounds that preferentially react with the protein of interest. This methodology has been successfully applied to identify selective covalent fragments against several drug targets, including SARS-CoV-2 main protease, cyclin-dependent kinase 2, and RAP27A. Here, we demonstrate the application of qIT to a target protein to generate a quantitative and robust data set, allowing prioritization of hit ligands for future development.

Subjects

MeSH terms (MEDLINE)

Small Molecule LibrariesDrug DiscoverySARS-CoV-2HumansLigandsGlutathioneCysteineCyclin-Dependent Kinase 2Drug Evaluation, Preclinical

Substances

Small Molecule LibrariesLigandsGlutathioneCysteineCyclin-Dependent Kinase 2

Authors and institutions

  • Department of Chemistry, Imperial College London, Molecular Sciences Research Hub; Department of Life Sciences, Imperial College London, South Kensington Campus.
  • Department of Chemistry, Imperial College London, Molecular Sciences Research Hub.
  • Department of Life Sciences, Imperial College London, South Kensington Campus; d.mann@imperial.ac.uk.

Cite

APA

Brown, C. P., Armstrong, A., & Mann, D. J. (2025). Covalent Fragment Screening Using the Quantitative Irreversible Tethering Assay. Journal of Visualized Experiments. https://doi.org/10.3791/67178

Vancouver

Brown CP, Armstrong A, Mann DJ. Covalent Fragment Screening Using the Quantitative Irreversible Tethering Assay. Journal of Visualized Experiments. 2025. doi:10.3791/67178

BibTeX
@article{Brown2025,
  author = {Brown, Charles P and Armstrong, Alan and Mann, David J},
  title = {Covalent Fragment Screening Using the Quantitative Irreversible Tethering Assay},
  journal = {Journal of Visualized Experiments},
  year = {2025},
  doi = {10.3791/67178}
}
Start for free →